Disposition of glutathione conjugates in rats by a novel glutamic acid pathway: Characterization of unique peptide conjugates by liquid chromatography/mass spectrometry and liquid chromatography/NMR

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 2, 2000, Pages 735-745

  Mutlib, Abdul E ^a   Shockcor, John ^a   Espina, Robert ^a   Graciani, Nilsa ^a   Du, Alicia ^a   Gan, Liang Shang ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; CARBOXYLIC ACID; CYSTEINE; CYSTEINYLGLYCINE; DIPEPTIDE; GLUTAMIC ACID; GLUTATHIONE DERIVATIVE; PARACETAMOL; SYNTHETIC PEPTIDE; TETRAPEPTIDE; TRIPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FRACTIONATION; CONJUGATE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG CONJUGATION; DRUG DISPOSITION; DRUG URINE LEVEL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ACETAMINOPHEN; ANIMALS; BILE; CHROMATOGRAPHY, LIQUID; DIPEPTIDES; GLUTAMIC ACID; GLUTATHIONE; KIDNEY; LIVER; MALE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

EID: 0033914344     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abbott WA, Griffith OW and Meister A (1986) Glutamyl-glutathione: Natural occurrence and enzymology. J Biol Chem 261:13657-13661.
2. Anders MW, Elfarra AA and Lash LH (1987) Cellular effects of reactive intermediates: Nephrotoxicity of S-conjugates of amino acids. Arch Toxicol 60:103-108.
3. Anders MW, Lash L, Dekant W, Elfarra AA and Dohn DR (1988) Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. CRC Crit Rev Toxicol 18:311-342.
4. Baillie TA and Davis MR (1993) Mass spectrometry in the analysis of glutathione conjugates. Biol Mass Spectrom 22:319-325.
5. Burlingame AL, Baillie TA and Russell DH (1992) Mass spectrometry. Anal Chem 64:467R-502R (and references cited therein).
6. Commandeur JNM, Stijntjes GJ and Vermeulen NPE (1995) Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates: Role in bioactivation and detoxification mechanisms of xenobiotics. Pharmacol Rev 47:271-330.
7. Dahlin DC, Miwa GT, Lu AYH and Nelson SD (1984) N-Acetyl-P-benzoquinone imine: A cytochrome P-450 mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81:1327-1331.
8. Draper WM, Brown FR, Bethem R and Miller MJ (1989) Thermospray mass spectrometry and tandem mass spectrometry of polar, urinary metabolites and metabolic conjugates. Biomed Environ Mass Spectrom 18:767-774.
9. Elfarra AA and Anders MW (1984) Renal processing of glutathione conjugates: Role in nephrotoxicity. Biochem Pharmacol 33:3729-3732.
10. Habig WH, Pabst MJ and Jakoby WB (1974) Glutathione S-transferases: The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
11. Haroldsen PE, Reilly MH, Hughes H, Gaskell SJ and Porter CJ (1988) Characterization of glutathione conjugates by fast atom bombardment/tandem mass spectrometry. Biomed Environ Mass Spectrom 15:615-621.
12. Hinchman CA andd Ballatori (1990) Glutathione-degrading capacities of liver and kidney in different species. Biochem Pharmacol 40:1131-11135.
13. Hinson JA, Monks TJ, Hong M, Highet RJ and Pohl LR (1982) 3-(Glutathion-S-yl)acetaminophen: A biliary metabolite of acetaminophen. Drug Metab Dispos 10:47-50.
14. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR and Brodie BB (1973) Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 187:195-202.
15. Ketterer B (1986) Detoxification reactions of glutathione and glutathione transferases. Xenobiotica 16:957-973.
16. King DS, Fields CG and Fields GB (1990) A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int J Pept Prot Res 36: 255-266.
17. Koob M and Dekant W (1991) Bioactivation of xenobiotics by formation of toxic glutathione conjugates. Chem-Biol Interact 77:107-136.
18. Lash LH and Anders MW (1986) Bioactivation and cytotoxicity of amino acid and glutathione S-conjugates. Comments Toxicol 1:87-112.
19. Lindon JC, Nicholson JK, Sidelmann UG and Wilson ID (1997) Directly coupled HPLC NMR and its application to drug metabolism. Drug Metab Rev 29:705-747.
20. Monks TJ and Lau SS (1989) Sulphur conjugate-mediated toxicity. Rev Biochem Toxicol 10:41-90.
21. Monks TJ, Lau SS, Highet RJ and Gillette JR (1985) Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. Drug Metab Dispos 13:553-559.
22. Muck WM and Henion JD (1990) High-performance liquid chromatography/tandem mass spectrometry: Its use for the identification of stanozolol and its major metabolites in human and equine urine. Biomed Environ Mass Spectrom 19:37-51.
23. Mutlib AE, Chen H, Nemeth G, Gan L and Christ DD (1999) LC/MS and high field NMR characterization of novel mixed diconjugates of the non-nucleoside HIV-1 reverse transcriptase inhibitor, efavirenz. Drug Metab Dispos 27:1045-1056.
24. Mutlib AE, Strupczewski J and Chesson S (1995) Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone. Drug Metab Dispos 23:951-964.
25. Nash JA, King LJ, Lock EA and Green T (1984) The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. Toxicol Appl Pharmacol 73:124-137.
26. Pallante SL, Lisek CA, Dulik DM and Fenselau C (1986) Glutathione conjugates: Immobilized enzyme synthesis and characterization by fast bombardment mass spectrometry. Drug Metab Dispos 14:313-318.
27. Shockcor JP, Wurm RM, Frick LW, Sanderson PN, Farrant RD, Sweatman BC and Lindon JC (1996) HPLC NMR identification of the human urinary metabolites of (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine, a nucleoside analogue active against human immunodeficiency virus (HIV). Xenobiotica 26: 189-199.
28. 1H-NMR spectroscopy to investigate the human urinary excretion of flurbiprofen metabolites. J Pharm Biomed Appl 11:1009-1015.
29. Streeter AJ, Dahlin DC, Nelson SD and Baillie TA (1984) The covalent binding of acetaminophen to protein: Evidence for cysteine residues as major sites of arylation in vitro. Chem-Biol Interact 48:349-366.
30. Tang W and Abbott FS (1996) Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation: LC/MS/MS characterization of the GSH-glucuronide diconjugates. Chem Res Toxicol 9:517-526.
31. Vamvaka S, Dekant W, Berthold K, Schmidt S, Wild D and Henschler D (1987) Enzymic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. Biochem Pharmacol 36:2741-2748.
32. Weidolf LO, Lee ED and Henion JD (1988) Determination of boldenone sulfoconjugates and related steroid sulfates in equine urine by high performance liquid chromatography/mass spectrometry. Biomed Environ Mass Spectrom 15:283-289.